Fundraising Fox

Pretzel Therapeutics

<UNKNOWN> · 3 known investors

pretzeltx.com ↗

Pretzel Therapeutics develops therapeutics targeting bioenergetic dysfunction and mitochondrial disease by addressing defects in mitochondrial DNA function and gene expression. The company leverages expertise in mitochondrial biology and drug discovery to create treatments for diseases associated with mitochondrial dysregulation.

BiotechDeep TechHealthtechMedical Devices

Founders & leadership

JP
Jay ParrishChief Executive Officer & Chairman of the Board
MM
Michal MinczukCo-Founder
GM
Gabriel MartinezChief Scientific Officer & Co-Founder
CG
Claes GustafssonCo-Founder
MF
Maria FalkenbergCo-Founder
NL
Nils-Göran LarssonCo-Founder

Investors · 3

ARCH Venture Partners✓ verifiedChicago
Cambridge Innovation Capital✓ verifiedCambridge, Cambs
EIR Ventures✓ verifiedStockholm

In the news